Ph 2 Double-blind, Double-dummy, Multictr, Prospective, Rand Study of PK of LCP-Tacro Tablets Once Daily, Compared to Prograf Caps, Twice Daily, for Prevention of Acute Allograft Rejection in De Novo Adult Kidney Transplant Recipients

Trial Profile

Ph 2 Double-blind, Double-dummy, Multictr, Prospective, Rand Study of PK of LCP-Tacro Tablets Once Daily, Compared to Prograf Caps, Twice Daily, for Prevention of Acute Allograft Rejection in De Novo Adult Kidney Transplant Recipients

Recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Jul 2015

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Renal transplant rejection
  • Focus Pharmacokinetics
  • Sponsors Veloxis Pharmaceuticals
  • Most Recent Events

    • 05 Dec 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 22 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top